The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...
Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...
Interim results from three trials exploring the use of Alpha DaRT® in treating pancreatic cancer showing high disease control rate, impressive overall survival in sub-group analyses, and positive safe ...
For patients with unresectable, non-metastatic hepatocellular carcinoma, Lenvima plus Keytruda in combination with TACE improved outcomes. Among patients with unresectable, non-metastatic ...
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on ...
Renowned artist Matt Ferguson has also designed a brand-new poster to mark the re-release, which you can check out below. For many fans, Revenge of the Sith stands out as the best film of the ...
Merck said its “once-in-a-lifetime” drug Keytruda could be subject to price reductions under the Inflation Reduction Act, which would lead to a … ...
Merck is bracing for the years of sales growth from oncology superstar Keytruda to take a sharp turn in 2028—and for more reasons than one. Along with a key U.S. patent expiring at the end of ...
"Goes from 0 to 1939 in 3 seconds," says the poster from campaign group Everyone Hates Elon as a slump in European Tesla sales also makes headlines. By Lily Ford It appears Elon Musk has enemies ...
(Reuters) -Drugmaker Merck said on Tuesday it expects its top selling cancer therapy Keytruda to be selected in 2026 for government price setting, which would become effective on January 1, 2028. The ...
currently in development as a co-therapy with KEYTRUDA (pembrolizumab) for advanced melanoma patients. Dr Mat Robinson, Microbiotica’s Senior Vice-President of Research, presented data from new ...
A new poster mocking Tesla CEO Elon Musk, who is also an adviser to U.S. President Donald Trump, appeared in a London advertisement space in late February 2025, specifically at a bus stop on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback